Article

Artificial intelligence platform, RADR®, aids in the discovery of DNA damaging agent for the ultra-rare cancer Atypical Teratoid Rhabdoid Tumors

2022-10-11

Abstract excerpt

Over the last decade the next-generation sequencing and ‘omics techniques have become indispensable tools for medicine and drug discovery. These techniques have led to an explosion of publicly available data that often goes under-utilized due to the lack of bioinformatic expertise and tools to analyze that volume of data. Here, we demonstrate the power of applying two novel computational platforms, the NCI’s CellM...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: a6e7ad81-776f-5d8e-a33e-0704dd5c9573
DOI: 10.3389/fddsv.2022.1033395

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Artificial intelligence platform, RADR®, aids in the discovery of DNA damaging agent for the ultra-rare cancer Atypical Teratoid Rhabdoid TumorsDOI 10.3389/fddsv.2022.1033395Read

Paediatric Strategy Forum for medicinal product development of DNA damage response pathway inhibitors in children and adolescents with cancer: ACCELERATE in collaboration with the European Medicines Agency with participation of the Food and Drug AdministrationSemantic proximity Read

Genome-wide CRISPR and small-molecule screens uncover targetable dependencies in ATRTSemantic proximity Read

Multi-Omics Analysis of NCI-60 Cell Line Data Reveals Novel Metabolic Processes Linked with Resistance to Alkylating Anti-Cancer AgentsSemantic proximity Read

Systematic review of pharmacogenomics and adverse drug reactions in paediatric oncology patients.Semantic proximity Read

Therapeutical interference with the epigenetic landscape of germ cell tumors: a comparative drug study and new mechanistical insightsSemantic proximity Read

Identification and validation of a non-genetically encoded vulnerability to XPO1 inhibition in malignant rhabdoid tumors – expanding patient-driven discovery beyond the N-of-1Semantic proximity Read

Targeted Therapy for Adrenocortical Carcinoma: A Genomic-Based Search for Available and Emerging OptionsSemantic proximity Read

Multiplex Screening for Interacting Compounds in Paediatric Acute Myeloid Leukaemia.Semantic proximity Read

Targeting the p53 pathway to treat Malignant Rhabdoid and Atypical Teratoid Rhabdoid TumorsSemantic proximity Read

The primary mechanism of cytotoxicity of the chemotherapeutic agent CX-5461 is topoisomerase II poisoningSemantic proximity Read

RUVBL1 and RUVBL2 are druggable MYCN regulators in neuroblastomaSemantic proximity Read

Olaparib for childhood tumors harboring defects in DNA damage repair genes: arm H of the NCI-COG Pediatric MATCH trialSemantic proximity Read